Hormone Foundation Offers Patient Guidance Following FDA Avandia Ruling

Main Category: Diabetes
Also Included In: Endocrinology
Article Date: 26 Sep 2010 - 0:00 PDT


The FDA ruled to keep the glucose control drug Avandia on the market, with significant restrictions. Dr. Robert A. Vigersky, the immediate past president of The Endocrine Society, offers guidance to type 2 diabetes patients in a video interview available on the Hormone Foundation Web site.

In light of the FDA decision, this educational video provides patients with next steps to consider in their diabetes management, explains the potential health risks of abruptly stopping diabetes medications and guides those in need of an endocrinologist to the Foundation's referral directory of 3,000 physicians.

The Endocrine Society, the American Diabetes Association and the American Association of Clinical Endocrinologists are issuing a joint news release responding to the FDA ruling.

The Hormone Foundation offers the following advice for people taking medication for type 2 diabetes:

- Do not stop taking your diabetes medications without first discussing it with your health care provider. Stopping your medications can cause poorer diabetes control with higher blood glucose (sugar) levels.

- It is important to maintain good glucose control to avoid the serious short- and long-term health problems of diabetes.

- Other types of diabetes medication are available which your health care provider may consider prescribing.

Source:
Hormone Foundation
Endocrine Society

• Additional
• References
• Citations